Fonar (FONR) | Stock Overview & Key Data
Fonar Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $310.00 on December 6, 1982
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Fonar
FONR
|
118.64M Micro-cap | 0.95% | 0.90% | 2.86% | 32.66% | 3.08% | 31.72% | 13.49% | 5.18% | 16.25% | 827.18% | 55.92% |
|
Thermo Fisher
TMO
|
174.55B Large-cap | 7.56% | 4.21% | -5.21% | -16.94% | -18.64% | 22.27% | -5.31% | 9.75% | 222.18% | 684.25% | 1,233.99% |
|
Danaher
DHR
|
126.39B Large-cap | 1.91% | 1.19% | -14.51% | -22.28% | -23.56% | -3.81% | -12.18% | -14.95% | 176.52% | 423.71% | 744.91% |
| 221.68M Micro-cap | -32.63% | -43.92% | -62.40% | -55.60% | -51.02% | 200.65% | 285.12% | -65.34% | -62.16% | -62.16% | -62.16% | |
|
Biodesix
BDSX
|
107.54M Micro-cap | 4.25% | 37.00% | -1.97% | 97.19% | 139.01% | 170.20% | -39.56% | -94.00% | -93.44% | -93.44% | -93.44% |
|
Oncocyte
OCX
|
65.62M Micro-cap | -4.35% | 47.37% | 24.70% | 6.94% | -13.97% | 87.05% | 41.14% | -93.86% | -92.52% | -95.03% | -95.03% |
Ownership & Short Interest
Calculate Your Fonar Investment Returns
Long-Term Investment Performance Analysis
Fonar stock price in May 2016 was $16.43, A $1,000.00 lump sum investment in Fonar made 10 years ago would be worth approximately $1,161.90 today, representing a positive return of 16.19%. This translates to an annualized return (CAGR) of 1.51%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is FONR's 52-week high and low?
- In the last 52 weeks, Fonar reached a high of $19.16 (on June 2, 2026) and a low of $13.62 (on June 20, 2025).
- What is the market cap and P/E ratio for FONR?
- Curious about Fonar's size and valuation? Its market capitalization stands at 118.64M. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.35, and the forward P/E (looking ahead) is N/A.
- Does FONR pay dividends? If so, what's the yield?
- As for dividends, Fonar isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Fonar's main competitors or similar companies to consider before investing?
When looking at Fonar, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO174.55B Healthcare Diagnostics & Research 22.27% -5.31% Danaher
DHR126.39B Healthcare Diagnostics & Research -3.81% -12.18% Burning Rock Biotech
BNR221.68M Healthcare Diagnostics & Research 200.65% 285.12% Biodesix
BDSX107.54M Healthcare Diagnostics & Research 170.20% -39.56% Oncocyte
OCX65.62M Healthcare Diagnostics & Research 87.05% 41.14% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Fonar Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Fonar's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.01%, the Debt to Equity ratio from the most recent quarter is 24.44, and its Gross Profit Margin stands at 37.95%.
- What is the recent revenue and earnings growth for FONR?
- Looking at Fonar's growth, its revenue over the trailing twelve months (TTM) was $106M. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.40%, and quarterly earnings saw a YoY growth of 4.70%.
- How much of FONR stock is held by insiders and institutions?
- Wondering who owns Fonar stock? Company insiders (like executives and directors) hold about 12.28% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 45.39%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.